Kaplan Fox & Kilsheimer LLP announced an investigation into Alignment Healthcare, Inc. for potential securities law violations. The investigation follows a July 8, 2026 whistleblower complaint by a former executive alleging accounting irregularities that artificially inflated previously reported and projected financial results, including Adjusted EBITDA, a key non-GAAP metric tied to executive compensation. The complaint claims millions of dollars in operating expenses were systematically misclassified as capital expenditures. On the same day, Alignment Healthcare stock fell $4.02 per share, or 16.7%, to close at $20.03 per share.
Alignment Healthcare LLCInvestigation for securities law violations and whistleblower complaint alleging accounting irregularities.